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Death-associated protein kinase (DAPK) is a member of the
Ca
2+/calmodulin-regulated family of serine/threonine protein
kinases. The role of the kinase activity of DAPK in eukaryotic
cell apoptosis and the ability of bioavailable DAPK inhibitors
to rescue neuronal death after brain injury have made it a
drug-discovery target for neurodegenerative disorders. In
order to understand the recognition of nucleotides by DAPK
and to gain insight into DAPK catalysis, the crystal structure
of human DAPK was solved in complex with ADP and Mg
2+
at 1.85 A ˚ resolution. ADP is a product of the kinase reaction
and product release is considered to be the rate-limiting step
of protein kinase catalytic cycles. The structure of DAPK–
ADP–Mg
2+ was compared with a newly determined DAPK–
AMP-PNP–Mg
2+ structure and the previously determined apo
DAPK structure (PDB code 1jks). The comparison shows that
nucleotide-induced changes are localized to the glycine-rich
loop region of DAPK.
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Death-associated protein kinase (DAPK) is a pro-apoptotic
Ca
2+/calmodulin-regulated serine/threonine protein kinase
(Cohen et al., 1997) that is a drug-discovery target for acute
central nervous system (CNS) injuries (Schumacher, Velentza
& Watterson, 2002; Velentza et al., 2003; Craft et al., 2004;
Shamloo et al., 2005). Acute CNS injuries such as stroke and
traumatic brain injury are major causes of death, but the larger
societal impact is subsequent morbidity, with life-long com-
promised functioning among most survivors. Related to the
latter point, single-nucleotide polymorphisms (SNPs) in the
human DAPK gene have recently been shown to correlate
with susceptibility to age-onset Alzheimer’s disease (Li et al.,
2006). The major impact of these disorders on health and
morbidity and the lack of any disease-altering therapies have
brought about a high level of scientiﬁc interest in the structure
and function of DAPK.
Insight into the in vivo mechanisms by which DAPK could
be involved in CNS pathophysiology (Schumacher, Velentza,
Watterson et al., 2002; Velentza et al., 2003; Craft et al., 2004;
Shamloo et al., 2005) has been provided by the identiﬁcation
(Schumacher et al., 2004, 2006) of endogenous CNS protein
substrates for DAPK. For example, the phosphorylation and
inactivation of a downstream calmodulin-regulated protein
kinase involved in neuronal survival by DAPK (Schumacher et
al., 2004) and the demonstration that DAPK is an S6 kinase
that could alter neuronal cell protein biosynthesis (Schu-
macher et al., 2006) raise the possibility that DAPK is involvedin phosphorylation cascades that modulate the neuronal
dysfunction or programmed cell death brought about by stress
or injury. The participation of DAPK as an early step in an
intracellular protein phosphorylation cascade before the cell is
committed to death provides one possible explanation of how
a single administration of a bioavailable DAPK inhibitor
(Velentza et al., 2003) in an early clinically relevant post-injury
therapeutic time window can lead to the subsequent obser-
vation of improved neurologic outcomes (Velentza et al., 2003;
Shamloo et al., 2005). Overall, in vivo studies and biochemical
investigations have established the importance of the DAPK
catalytic domain in pathophysiology progression and its
potential as a therapeutic target.
Insight into the structural basis of the catalytic activity of
DAPK was initially obtained by determination of the high-
resolution crystal structures of the constitutively active DAPK
catalytic domain in an apo form and in various complexes
containing the ATP analog AMP-PNP (Tereshko et al., 2001),
combined with molecular model building and activity analyses
of peptide-substrate preferences (Velentza et al., 2001).
Although crystallographic data are static representations of an
average structure, the accumulation of structures of various
complexes can provide insights related to the catalytic cycle. It
has been noted (Nolen et al., 2003) that examples of direct
comparisons of protein kinase structures in the ADP-bound
and AMP-PNP-bound forms, which reﬂect nucleotide product
and substrate complexes, respectively, are limited. While
additional serine/threonine protein kinase catalytic domain
structures (Aoki et al., 2004) and various complexes (Yang et
al., 2004) have been reported more recently, examples for
the calmodulin-regulated protein kinase family are lacking.
Therefore, we determined the structure of the DAPK–ADP–
Mg
2+ complex, based on the rationale that release of ADP is a
rate-limiting step in protein kinase-mediated catalytic cycles
(Adams, 2001), and compared its structure with that con-
taining the hydrolysis-resistant ATP analog AMP-PNP and
Mg
2+ as well as with that of the apo form of DAPK.
Our results presented here provide the ﬁrst DAPK–ADP–
Mg
2+ structure and the comparisons among different confor-
mations reveal apparent nucleotide-induced changes in the
DAPK structure that are localized to the glycine-rich loop
region. The glycine-rich loop is a conserved region of protein
kinases that has been proposed to be essential for catalysis
(Johnson et al., 2001) and is described by the consensus
sequence -Gly-X-Gly-X-X-Gly. The ﬁrst and second glycines
occur in 95 and 99% of kinases, respectively, while the third
glycine is conserved in 85% of kinases (Hemmer et al., 1997).
DAPK is among the 15% of kinases that lack the third glycine.
The results obtained in this study allow a comparative analysis
across the three conformations of DAPK.
2. Materials and methods
2.1. Enzyme preparation
The constitutively active catalytic domain of human DAPK,
consisting of amino acids 1–285 of the cDNA open reading
frame, was expressed and puriﬁed as described previously
(Velentza et al., 2001), except for the anion-exchange chro-
matography step. Brieﬂy, bacterial cultures were grown in
Luria broth at 310 K until the OD600 reached 0.6 and recom-
binant DNA-encoded expression of DAPK protein was in-
duced by the addition of 0.2 mg anhydrotetracycline per litre
of culture. Cultures were grown for an additional 3 h at 310 K
and cell pellets were then collected by centrifugation at 5100g
for 20 min and stored at 253 K. Rapidly thawed cell pellets
were subjected to sonication in 100 mM Tris pH 8.0, 0.25 M
NaCl, 0.01% Triton X-100, 0.7 mg l
 1 pepstatin A and 1 mM
DTT and then centrifuged at 39 000g for 40 min. The super-
natant was collected, loaded onto 5 ml Streptactin afﬁnity
resin (Qiagen, Valencia, California, USA) and washed with
100 mM Tris–HCl pH 8.0, 0.25 M NaCl; DAPK was eluted
with a buffer containing 2.5 mM desthiobiotin, 100 mM Tris–
HCl pH 8.0, 0.25 M NaCl. The sample was concentrated at
277 K using 10 000 molecular-weight cutoff concentrators
(Vivascience/Sartorius, Aubagne, France) at 5000g for 30 min
and the buffer was exchanged for a buffer consisting of 0.25 M
NaCl and 100 mM Tris pH 8.0. Puriﬁcation of human DAPK
for structures in the absence of Mg
2+ was performed as
described previously (Velentza et al., 2001). The protein con-
centration was determined by UVabsorbance at 280 nm using
a NanoDrop system (Wilmington, Delaware, USA) and a
molar extinction coefﬁcient of 92.7 g
 1 ml cm
 1. The protein
was homogenous by SDS–PAGE and gave the expected
molecular chain weight.
2.2. Crystallization and data collection
For the complex of DAPK with ADP (Sigma catalog No.
A5410; lot 50H7080) and Mg
2+, a protein solution at
5.5 mg ml
 1 in 100 mM Tris pH 8.0 and 0.25 M NaCl was
incubated with 1 mM ADP and 10 mM MgCl2 for 45 min at
277 K. Crystallization conditions were determined with
96-well plate NeXtal AmSO4 suite screens (catalog No.
130905; Qiagen, Valencia, California, USA) using the sitting-
drop method for crystallization. Crystals grew in 0.2 M
ammonium chloride, 2.2 M ammonium sulfate pH 5.27 at
295 K and were harvested, soaked in a cryoprotection solution
consisting of 0.2 M ammonium chloride, 2.2 M ammonium
sulfate, 38% sucrose, 50 mM MgCl2 and 2.8 mM ADP and
ﬂash-frozen in liquid nitrogen. Diffraction data were collected
using an MX-300 detector (Rayonix LLC, Evanston, Illinois,
USA) at 100 K on beamline 21-ID-G (LS-CAT) at the
Advanced Photon Source (APS).
For the complex of DAPK with AMP-PNP (Sigma catalog
No. A2647; lot 048 K5051) and Mg
2+, a protein solution at
5.5 mg ml
 1 in 100 mM Tris pH 8.0, 0.25 M NaCl was incu-
bated with 1 mM AMP-PNP and 10 mM MgCl2 for 45 min at
277 K. Crystallization conditions for DAPK–AMP-PNP–Mg
2+
were determined analogously to the DAPK–ADP–Mg
2+ con-
ditions using AmSO4 suite screens. Crystals grew in 0.2 M
NaCl, 2.2 M ammonium sulfate pH 5.25 at 295 K and were
harvested, soaked in a cryoprotection solution consisting of
0.2 M NaCl, 2.2 M ammonium sulfate, 30% sucrose, 6.0 mM
research papers
242 McNamara et al.   Death-associated protein kinase Acta Cryst. (2009). D65, 241–248AMP-PNP and 50 mM MgCl2 and ﬂash-frozen in liquid
nitrogen. Diffraction data were collected using an MX-300
detector (Rayonix LLC, Evanston, Illinois, USA) at 100 K on
beamline 21-ID-G (LS-CAT) at the APS.
2.3. Structure determination and refinement
The data sets were integrated and merged using HKL-2000
(Otwinowski & Minor, 1997). Both nucleotide complexes
belonged to the orthorhombic space group P212121, with unit-
cell parameters a = 46.8, b= 62.6, c= 88.4 A ˚ for DAPK–ADP–
Mg
2+ and a = 46.7, b= 62.5, c= 88.6 A ˚ for DAPK–AMP-PNP–
Mg
2+. Both structures were determined by molecular
replacement using MOLREP (Vagin & Teplyakov, 1997); apo
DAPK with waters removed at 1.5 A ˚ resolution (PDB code
1jks) was used as the search model. Interactive rounds of
model building were performed in Coot (Emsley & Cowtan,
2004), reﬁnement was performed with REFMAC5( M u r -
shudov et al., 1997) and solvent was added using ARP/wARP
(Perrakis et al., 1997). The DAPK–ADP–Mg
2+ structure (PDB
code 3f5g) had a ﬁnal crystallographic R factor and Rfree factor
of 0.19 and 0.24, respectively. The r.m.s. deviations from the
ideal values were 0.015 A ˚ for bond lengths and 1.57  for bond
angles. The DAPK–AMP-PNP–Mg
2+ structure (PDB code
3f5u) had a ﬁnal crystallographic R factor and Rfree factor of
0.18 and 0.25, respectively. The r.m.s.
deviations from the ideal values were
0.018 A ˚ for bond lengths and 1.77  for
bond angles. Data-collection and reﬁne-
ment statistics are shown in Table 1. The
structures of the nucleotide complexes
in the absence of Mg
2+ were determined
for the purpose of determining the
structural contribution of Mg
2+ to the
conformational differences observed on
superposition. The DAPK–ADP com-
plex (PDB code 3eh9) diffracted to
1.70 A ˚ resolution and the DAPK–
AMP-PNP complex (PDB code 3eha)
diffracted to 1.60 A ˚ resolution; both
were isomorphous to the other DAPK
structures. Superpositions of protein
structures were calculated over all
atoms using least-squares ﬁtting within
Coot (Emsley & Cowtan, 2004). Figures
were prepared using PyMOL (DeLano,
2002).
3. Results and discussion
3.1. Structure of DAPK–ADP–Mg
2+
(PDB code 3f5g)
The structure of DAPK complexed
with ADP is important because the
release of ADP is a rate-limiting step
in the kinase-mediated catalytic cycle
(Adams, 2001). Our goal was to deter-
mine how the recognition of ADP by DAPK induces changes
in the positioning of residues relative to other DAPK struc-
tures. We used cocrystallization of DAPK with ADP and Mg
2+
followed by soaking of DAPK crystals with ADP and Mg
2+ in
a cryoprotection solvent. Crystallizations were performed
under ammonium sulfate conditions similar to those described
previously (Tereshko et al., 2001; Velentza et al., 2003). The
crystals diffracted to 1.85 A ˚ resolution and were isomorphous
to previously determined DAPK structures.
The structure of DAPK–ADP–Mg
2+ (Fig. 1a) shows that the
structure has the canonical kinase fold consisting of a mainly
N-terminal  -sheet and a larger  -helical C-terminal domain.
The Fo   Fc OMIT map shows density corresponding to the
ADP molecule between the N-terminal and C-terminal
domains (Fig. 1b). Density for the adenine ring, the ribose
ring, phosphates and one magnesium ion is clearly identiﬁable.
3.2. Superposition of DAPK–ADP–Mg
2+ with apo DAPK
A superposition of DAPK–ADP–Mg
2+ and apo DAPK
(PDB code 1jks; Tereshko et al., 2001) was calculated by least-
squares ﬁtting (Emsley & Cowtan, 2004) over all atoms and an
r.m.s. deviation of 0.69 A ˚ was obtained. Overall, the structures
of DAPK–ADP–Mg
2+ and apo DAPK are mostly superim-
posable, except for localized differences in the hinge and
research papers
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Table 1
Data-collection and reﬁnement statistics.








PDB code 3f5g 3f5u
Space group P212121 P212121
Unit-cell parameters (A ˚ ) a = 46.8, b = 62.6,
c = 88.4
a = 46.7, b = 62.5,
c = 88.6
X-ray source 21-ID-G (LS-CAT) 21-ID-G (LS-CAT)
Wavelength (A ˚ ) 0.97857 0.97857
Resolution (A ˚ ) 30.0–1.85 (1.92–1.85) 30.0–2.0 (2.07–2.00)
No. of observations 159531 126280
No. of unique reﬂections 22396 (2154) 18512 (1132)
Cutoff criterion I <  3 (I) I <  3 (I)
Completeness (%) 98.08 (96.26) 99.05 (87.70)
Redundancy 3.8 (3.8) 6.8 (6.6)
Mean I/ (I) 10.6 (4.15) 9.10 (3.20)
Rmerge† (%) 0.066 (0.469) 0.068 (0.546)
Wilson B factor (A ˚ 2) 32.0 36.2
Model and reﬁnement statistics
Resolution range (A ˚ ) 30.0–1.85 30.0–2.00
No. of reﬂections 21206 17521
Final Rwork‡ 0.185 (0.197) 0.177 (0.199)
No. of reﬂections in test set for Rfree§ 1147 941
Final Rfree§ 0.244 (0.257) 0.245 (0.338)
R.m.s. deviation from ideal
Bond lengths (A ˚ ) 0.015 0.018
Bond angles ( ) 1.57 1.77
Average B factors (A ˚ 2) 25.7 30.3
Ramachandran plot analysis
Most favored regions (%) 90.4 91.5
Additionally allowed regions (%) 9.2 8.1
Generously allowed regions (%) 0.4 0.4













Fo. § 5% of the reﬂections were
reserved for calculation of Rfree.glycine-rich loop regions. The hinge region
has a slight change in positioning that starts
at the C
  atom of Val96 and continues
through residue Ala97. In the superposition,
the C
  atom of Ala97 in the DAPK–ADP–
Mg
2+ complex (PDB code 3f5g) differs by
0.85 A ˚ from the position of this atom in the
apo DAPK structure (Fig. 2). The deviation
in the glycine-rich loop of the DAPK
structures begins at the C
  atom of Glu17
and continues through Phe24. The structure
around Ser21 and Gly22 in DAPK–ADP–
Mg
2+ is apparently shifted towards the
C-terminal domain, resulting in a slight
closing of the loop compared with the apo
DAPK structure (Fig. 2). The amide N atom
of Ser21 in the DAPK–ADP–Mg
2+ structure
differs by 1.10 A ˚ from its position in the apo
DAPK structure. The highly conserved
Gly22 can be modeled in two conforma-
tions; the amide N of conformation A shown
in Fig. 2 differs by 0.93 A ˚ from the apo
DAPK structure, while the amide N of
conformation B (not shown in the ﬁgure)
differs by 0.74 A ˚ from the amide N of the
apo DAPK structure.
3.3. Structure of DAPK–AMP-PNP–Mg
2+
(PDB code 3f5u)
The structure of DAPK–ADP–Mg
2+ was
compared with the structures of DAPK–
AMP-PNP–Mg
2+ (PDB code 1jkk) and
DAPK–AMP-PNP–Mn
2+ (PDB code 1ig1)
in order to examine conformational differ-
ences between the proteins. This was also
performed to compare the detailed inter-
actions of the protein with the nucleotide
and the metal ion. However, the structures
1jkk and 1ig1 could not be used for com-
parison with DAPK–ADP–Mg
2+ owing to a
lack of discernible density for the nucleotide
 - and  -phosphates. Therefore, we deter-
mined a new crystal structure of DAPK–
AMP-PNP–Mg
2+ using a combination of
cocrystallization of DAPK with AMP-PNP
and MgCl2 followed by soaking of crystals in
a cryoprotection solution that contained
AMP-PNP and MgCl2, similar to the
method used to obtain the DAPK–ADP–
Mg
2+ complex. The DAPK–AMP-PNP–
Mg
2+ crystals grew in a high concentration
of ammonium sulfate and diffracted to
2.00 A ˚ resolution. The crystals were iso-
morphous to previously determined DAPK
structures. The data-collection and reﬁne-
ment statistics are shown in Table 1.
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Figure 1
The structure of DAPK–ADP–Mg
2+.( a) A representation of the overall structure of DAPK–
ADP–Mg
2+.( b)A nFo   Fc density map calculated with ADP and Mg
2+ omitted from the
model is shown contoured at +3  within the context of the surrounding protein residues.
Figure 2
Superposition by least-squares ﬁtting of DAPK–ADP–Mg
2+ and apo DAPK reveals little
change between the two structures apart from in two key areas: the hinge region near Ala97
and the glycine-rich loop near Ser21. The DAPK–ADP–Mg
2+ structure is shown in red and the
apo DAPK structure is shown in beige. Protein residues from the N-terminal domain and hinge
region are shown.The structure of DAPK–AMP-PNP–Mg
2+ (Fig. 3; PDB
code 3f5u) was determined and the Fo   Fc OMIT map
contained clear density for the nucleotide, including the  - and
 -phosphates and one magnesium ion. The positioning of the
 -phosphate in the new DAPK–AMP-PNP–Mg
2+ structure is
such that it is in a ‘kinked’ conformation similar to that
observed in other kinase–AMP-PNP structures such as PKA
(Kim et al., 2005), JNK3 (Xie et al., 1998), GSK3  (Aoki et al.,
2004), CDK2 (Brown et al., 1999) and phosphorylase kinase
(Lowe et al., 1997). Initial modeling and reﬁnement revealed
partial negative density located around the  -phosphate of the
nucleotide, despite the use of the highest purity nucleotide
available (see x2). However, this ﬁnding is not uncommon in
kinase structures. For example, observation of negative
density or a lack of density corresponding to the  -phosphate
of AMP-PNP in a kinase complex can be seen in the electron-
density maps of structures such as GSK3 –AMP-PNP (PDB
code 1pyx), Polo-like kinase 1 (PDB code 2ou7), CK2–AMP-
PNP (1lp4), Pim 1 kinase–AMP-PNP (PDB code 1yxt) and
serum/glucocorticoid regulated kinase–AMP-PNP (PDB code
2r5t). Nevertheless, our new DAPK–AMP-PNP–Mg
2+ data
provided an improvement in density that allowed modeling of
the  -phosphate. The adjustment of the occupancies of the
 -phosphate and the OG1, O2G and O3G atoms to 0.60
resulted in elimination of the negative density in the reﬁne-
ment model, thereby allowing a comparative analysis between
nucleotide-bound states.




The determination of a DAPK–ADP–Mg
2+ structure and a
DAPK–AMP-PNP–Mg
2+ structure with sufﬁcient density to
allow placement of the  - and  -phosphates facilitated a
comparison of the two protein conformations and examina-




2+ by a least-squares
ﬁt over all atoms revealed an r.m.s. deviation
of 0.67 A ˚ between the two structures.
Examination of the details of nucleotide




vealed conservation of some key distances
between the protein and the adenine and
ribose portions of the nucleotides (Figs. 4a
and 4b). For example, the adenine bases of
AMP-PNP and ADP make conserved
contacts with the hinge region of the kinase.
The N1 atoms of the adenine rings are both
3.1 A ˚ from the amide N atom of Val96. The
N6 atom of the adenine ring is 2.7 A ˚ away
from the carboxyl of Glu94. The ribose-ring
O2* and O3* atoms make conserved inter-
actions with Glu100 in the ADP and AMP-
PNP structures.
An examination of the protein–phos-
phate interactions revealed several contacts
that are conserved among the ADP and
AMP-PNP phosphates. The O2A atom of
the  -phosphate in the ADP and AMP-PNP
structures interacts with a water molecule
and the NZ atom of the catalytic Lys42. The
 -phosphates of both structures are within
proximity of the C
  atom of Gly22 of the
glycine-rich loop. Several differences can be
noted in the interactions of the  -phos-
phates. In the ADP structure the  -phos-
phate O3B atom is within proximity of the
Mg
2+ ion, while no  -phosphate atoms make
contact with the Mg
2+ ion of AMP-PNP. The
improved density of the  -phosphate of
AMP-PNP allows a closer examination of
protein atoms that are within hydrogen-
bonding distance of the  -phosphate atoms
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Figure 3
An Fo   Fc density map calculated with AMP-PNP and Mg
2+ omitted from the model is shown
contoured at +3  within the context of the surrounding protein residues. The positions of the
 - and  -phosphates can be identiﬁed; however, the  -phosphate has partial occupancy.
Figure 4
DAPK–nucleotide–Mg
2+ interactions. (a) ADP–Mg
2+ interactions with DAPK. (b) AMP-
PNP–Mg
2+ interactions with DAPK.and also those atoms within proximity that might be involved
in the phospho-transfer process. The only protein atom that is
within potential hydrogen-bonding distance is Asp139 OD1
(2.8 A ˚ ). Residues which are just beyond hydrogen-bonding
distance to the  -phosphate atoms but may aid in facilitating
phospho-transfer include Asp139 (OD1 atom, 3.2 A ˚ ), Glu143
(OE2 atom, 4.0 A ˚ ), Gly22 (N atom, 4.4 A ˚ ), Gln23 (N atom,
3.7 A ˚ ) and Asn144 (ND2 atom, 4.4 A ˚ ).
In both the AMP-PNP-bound and ADP-bound forms, one
magnesium ion is found in each structure. However, it cannot
be ruled out that DAPK can bind two Mg
2+ ions based on the
current crystal structures. This is because the ammonium
sulfate crystallization conditions may have competed with a
weakly bound second Mg
2+ ion. Most kinases will bind two
magnesium ions (Adams, 2001). The ﬁrst site (Mg1) involves
the chelation of the  - and  -phosphates with a conserved
Asp. The second site (Mg2) is involved in chelation of the  -
and  -phosphates and is near a conserved Asp and a
conserved Asn. The exact roles of the magnesium ions in
catalysis can differ between kinases. In PKA, the ﬁrst site is
activating and the second site is inhibitory (Adams, 2001). It
has been noted (Nolen et al., 2003) that CDK2, casein kinase 1
and CK2  are examples of active protein kinases with bound
ATP or ADP which bind only one Mg
2+ ion in the Mg2 site.
DAPK is similar to other kinases in that it binds one Mg
2+ ion
in the Mg2 site in the AMP-PNP-bound and ADP-bound
forms, which may be the higher afﬁnity coordination site.
In a superposition of the ADP and AMP-PNP structures,
the location of the magnesium ion differs by 1.2 A ˚ (Fig. 5a).
The Mg
2+ ion in the ADP structure is coordinated to six O
atoms, which include the O1A atom of the  -phosphate, the
O3B atom of the  -phosphate, a water molecule, Glu143 OE2,
Asn144 OD1 and Asp161 OD1. In the
AMP-PNP structure, the Mg
2+ ion makes
fewer interactions with the protein residues
and only coordinates to Asp161 OD2, while
other interactions are made with the O1A
atom of the  -phosphate, the O3G and O2G
atoms of the  -phosphate and a water
molecule. An inspection of the crystal
structure of an ADP complex obtained in
the absence of Mg
2+, DAPK–ADP (PDB
code 3eh9), reveals an alternative confor-
mation of the  -phosphate. In this alter-
native conformation, the phosphate is in a
similar location to the position where Mg
2+
binds. This raises the possibility that the role
of Mg
2+ is to assist in the selection of a
catalytically preferred conformation of the
 -phosphate. In the AMP-PNP structure
obtained in the absence of Mg
2+, DAPK–
AMP-PNP (PDB code 3eha), only subtle
changes in interaction distances are seen
between the diaxial O atoms of the  - and  -
phosphates and the glycine-rich loop. For
example, in the absence of Mg
2+, the amide
N interaction distances to the diaxial O
atom of the  -phosphate are 3.3 A ˚ to Ala25
and 2.9 A ˚ to Asn24. In the Mg
2+ structure,
these distances are increased to 3.8 and
4.4 A ˚ , respectively.
3.5. Comparison of the glycine-rich loop
conformations of DAPK structures




structures revealed an interesting structural
change in the glycine-rich loop region.
Similar to the comparisons of DAPK–ADP–
Mg
2+ with the apo and AMP-PNP- and
Mg
2+-bound forms, a superposition of the
DAPK–AMP-PNP–Mg
2+ structure and the
research papers
246 McNamara et al.   Death-associated protein kinase Acta Cryst. (2009). D65, 241–248
Figure 5
Comparisons of the glycine-rich loop. (a) Superposition of the glycine-rich loops of apo DAPK
(beige), DAPK–ADP–Mg
2+ (red) and DAPK–AMP-PNP–Mg
2+ (blue) and their position
relative to the nucleotide. The DAPK–AMP-PNP–Mg
2+ loop has the most closed con-
formation. Residues 17–28 are shown for simplicity. The calculated r.m.s. deviation over the C
 
atoms of residues 20–25 between the apo DAPK structure and the DAPK–AMP-PNP–Mg
2+
structure is 1.03 A ˚ and that between the apo DAPK and DAPK–ADP–Mg
2+ structures is
0.62 A ˚ .( b)2 Fo   Fc electron-density map at 1.0  of the glycine-rich loop of DAPK–ADP–
Mg
2+. One conformation of Gln23 is modeled such that the side chain is within proximity of the
 -phosphate (conformation B). (c)2 Fo   Fc electron-density map of the glycine-rich loop of
DAPK–AMP-PNP–Mg
2+. The side chain of Phe24 in the DAPK–AMP-PNP structure can be
modeled in the ‘open’ conformation (B) or a conformationally restricted position (A).apo DAPK structure (PDB code 1jks) was calculated so that a
comparison of r.m.s deviation values could be generated
among all three structures. The r.m.s. deviation was 0.59 A ˚ ,
which is comparable to the other superpositions. Although all
three structures generally superimposed, differences were
noted in the topology of the glycine-rich loop encompassing
amino acids 20–25 (Fig. 5a). Comparatively, the DAPK–AMP-
PNP–Mg
2+ structure is a more closed structure, the apo DAPK
(PDB code 1jks) structure is a more open structure and the
DAPK–ADP–Mg
2+ structure is intermediate between the two.
The variance of the glycine-rich loop conformations relative
to the apo DAPK structure is reﬂected in the r.m.s. deviation
values calculated over the C
  atoms for residues 20–25. The
r.m.s. deviation for these residues between apo DAPK and
DAPK–AMP-PNP–Mg
2+ is 1.03 A ˚ and that between apo
DAPK and DAPK–ADP–Mg
2+ is 0.62 A ˚ . A closed confor-
mation of the DAPK–AMP-PNP–Mg
2+ and DAPK–ADP–
Mg
2+ structures indicates that the loop is more ordered, or
conformationally restricted, by the phosphate interactions.
Stabilization of the glycine-rich loop by an ATP analog is
consistent with studies of other protein kinases (Xie et al.,
1998; Johnson et al., 2001). An active-site opening and closing
that involves changes in the glycine-rich loop conformation
would be consistent with the prevailing model of conforma-
tional ﬂexibility being essential for catalysis (Johnson et al.,
2001). However, the observation that AMP-PNP takes the
most closed conformation has not always been observed, as in
the case of complexes of the serine-speciﬁc kinase Sky1p
(Nolen et al., 2003). The trend of a comparatively open and
ﬂexible conformation for DAPK–ADP–Mg
2+ compared with
DAPK–AMP-PNP–Mg
2+ might be related to the release of the
reaction products ADP and the phosphorylated peptide.
Several assumptions have been made in modeling side
chains in this region that deserve mention. Firstly, Gln23 in the
glycine-rich loop region is modeled in two different confor-
mations in the DAPK–ADP–Mg
2+ structure and in two
different conformations in the DAPK–AMP-PNP–Mg
2+
structure (Figs. 5b and 5c). Interestingly, a possible stabilizing
role of the Gln23 side chain in the ADP structure is suggested
by the 2.8 A ˚ distance between Gln23 NE2 and the O3B atom
of the  -phosphate (Fig. 4a). The position of Gln23 NE2
occupies the same location as the position of the  -phosphate
in the AMP-PNP structure. In the AMP-PNP structure, the
NE2 atom is modeled in a position that is within proximity of
the  -phosphate; however, at 1.0  density can only be seen for
the CA and CB atoms for this conformation, so it is unclear
whether Gln23 NE2 is involved in an interaction with the
 -phosphate O atoms (Fig. 5c). The results raise the possibility
that Gln23 might be important in the catalytic cycle owing to
its potential hydrogen-bonding capability with the  -phos-
phate of ADP and possibly the  -phosphate of AMP-PNP,
thereby contributing to the conformational adaptability that is
key to catalysis.
Secondly, Phe24 also appears to have conformational
variability. The conformation of the side chain of Phe24 in apo
DAPK and DAPK–ADP–Mg
2+ is up towards the N-terminal
domain. In the AMP-PNP-bound form, an alternative
conformation of Phe24 with the side chain down towards the
C-terminal domain can be modeled in a conformation distinct
from the conformation in DAPK–ADP and apo DAPK
(Fig. 5c). The two conformations result in a 1.6 A ˚ difference in
the C
  atom of Phe24.
The three DAPK conformations demonstrate that nucleo-
tide binding brings about changes in conformation that are
mostly localized to the glycine-rich loop region. This trend is
consistent with the results for other protein kinases (Yang et
al., 2004; Xie et al., 1998; Nolen et al., 2003; Eswaran et al.,
2007; Lowe et al., 1997). Interestingly, Gln23 within the
glycine-rich loop may play a role in regulating ADP binding/
release, which is the rate-limiting step in the catalytic
mechanism. The mutagenesis of this residue and an exam-
ination of the effects on catalytic activity would be an inter-
esting test of the hypothesis in future studies.
4. Conclusions
The determination of the ﬁrst DAPK–ADP–Mg
2+ structure
and the determination of a new DAPK–AMP-PNP–Mg
2+
structure allowed a comparative analysis of three different
DAPK conformations relevant to the catalytic cycle: a form
containing no bound nucleotide, a form containing a non-
hydrolyzable analog of the ATP substrate and a form
containing the reaction product ADP. The comparisons
revealed discrete localized conformational changes in DAPK
as a result of changes in nucleotide binding. The most notable
conformational changes occur in the glycine-rich loop region,
an active-site region with potential for modulation of kinase
activity.
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